Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study.

Cardona A, Day FR, Perry JRB, Loh M, Chu AY, Lehne B, Paul DS, Lotta LA, Stewart ID, Kerrison ND, Scott RA, Khaw KT, Forouhi NG, Langenberg C, Liu C, Mendelson MM, Levy D, Beck S, Leslie RD, Dupuis J, Meigs JB, Kooner JS, Pihlajamäki J, Vaag A, Perfilyev A, Ling C, Hivert MF, Chambers JC, Wareham NJ, Ong KK.

Diabetes. 2019 Sep 10. pii: db180290. doi: 10.2337/db18-0290. [Epub ahead of print]

PMID:
31506343
2.

The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies.

Yu B, Zanetti KA, Temprosa M, Albanes D, Appel N, Barrera CB, Ben-Shlomo Y, Boerwinkle E, Casas JP, Clish C, Dale C, Dehghan A, Derkach A, Eliassen AH, Elliott P, Fahy E, Gieger C, Gunter MJ, Harada S, Harris T, Herr DR, Herrington D, Hirschhorn JN, Hoover E, Hsing AW, Johansson M, Kelly RS, Khoo CM, Kivimäki M, Kristal BS, Langenberg C, Lasky-Su J, Lawlor DA, Lotta LA, Mangino M, Le Marchand L, Mathé E, Matthews CE, Menni C, Mucci LA, Murphy R, Oresic M, Orwoll E, Ose J, Pereira AC, Playdon MC, Poston L, Price J, Qi Q, Rexrode K, Risch A, Sampson J, Seow WJ, Sesso HD, Shah SH, Shu XO, Smith GCS, Sovio U, Stevens VL, Stolzenberg-Solomon R, Takebayashi T, Tillin T, Travis R, Tzoulaki I, Ulrich CM, Vasan RS, Verma M, Wang Y, Wareham NJ, Wong A, Younes N, Zhao H, Zheng W, Moore SC.

Am J Epidemiol. 2019 Jun 1;188(6):991-1012. doi: 10.1093/aje/kwz028.

3.

MicroRNA-196a links human body fat distribution to adipose tissue extracellular matrix composition.

Hilton C, Neville MJ, Wittemans LBL, Todorcevic M, Pinnick KE, Pulit SL, Luan J, Kulyté A, Dahlman I, Wareham NJ, Lotta LA, Arner P, Lindgren CM, Langenberg C, Karpe F.

EBioMedicine. 2019 Jun;44:467-475. doi: 10.1016/j.ebiom.2019.05.047. Epub 2019 May 28.

4.

Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.

Lotta LA, Mokrosiński J, Mendes de Oliveira E, Li C, Sharp SJ, Luan J, Brouwers B, Ayinampudi V, Bowker N, Kerrison N, Kaimakis V, Hoult D, Stewart ID, Wheeler E, Day FR, Perry JRB, Langenberg C, Wareham NJ, Farooqi IS.

Cell. 2019 Apr 18;177(3):597-607.e9. doi: 10.1016/j.cell.2019.03.044.

5.

Assessing the causal association of glycine with risk of cardio-metabolic diseases.

Wittemans LBL, Lotta LA, Oliver-Williams C, Stewart ID, Surendran P, Karthikeyan S, Day FR, Koulman A, Imamura F, Zeng L, Erdmann J, Schunkert H, Khaw KT, Griffin JL, Forouhi NG, Scott RA, Wood AM, Burgess S, Howson JMM, Danesh J, Wareham NJ, Butterworth AS, Langenberg C.

Nat Commun. 2019 Mar 5;10(1):1060. doi: 10.1038/s41467-019-08936-1.

6.

Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects.

Gorski MM, Lecchi A, Femia EA, La Marca S, Cairo A, Pappalardo E, Lotta LA, Artoni A, Peyvandi F.

Haematologica. 2019 Feb 28. pii: haematol.2018.204990. doi: 10.3324/haematol.2018.204990. [Epub ahead of print]

7.

Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.

Lotta LA, Wittemans LBL, Zuber V, Stewart ID, Sharp SJ, Luan J, Day FR, Li C, Bowker N, Cai L, De Lucia Rolfe E, Khaw KT, Perry JRB, O'Rahilly S, Scott RA, Savage DB, Burgess S, Wareham NJ, Langenberg C.

JAMA. 2018 Dec 25;320(24):2553-2563. doi: 10.1001/jama.2018.19329.

8.

Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.

Lotta LA, Stewart ID, Sharp SJ, Day FR, Burgess S, Luan J, Bowker N, Cai L, Li C, Wittemans LBL, Kerrison ND, Khaw KT, McCarthy MI, O'Rahilly S, Scott RA, Savage DB, Perry JRB, Langenberg C, Wareham NJ.

JAMA Cardiol. 2018 Oct 1;3(10):957-966. doi: 10.1001/jamacardio.2018.2866.

9.

Genome-wide association study for risk taking propensity indicates shared pathways with body mass index.

Clifton EAD, Perry JRB, Imamura F, Lotta LA, Brage S, Forouhi NG, Griffin SJ, Wareham NJ, Ong KK, Day FR.

Commun Biol. 2018 May 3;1:36. doi: 10.1038/s42003-018-0042-6. eCollection 2018.

10.

Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes.

de Haan HG, van Hylckama Vlieg A, Lotta LA, Gorski MM, Bucciarelli P, Martinelli I, Baglin TP, Peyvandi F, Rosendaal FR; INVENT consortium.

J Thromb Haemost. 2018 Dec;16(12):2432-2441. doi: 10.1111/jth.14279. Epub 2018 Oct 16.

11.

Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis.

Gorski MM, de Haan HG, Mancini I, Lotta LA, Bucciarelli P, Passamonti SM, Cairo A, Pappalardo E, van Hylckama Vlieg A, Martinelli I, Rosendaal FR, Peyvandi F.

Thromb Res. 2018 Sep;169:76-81. doi: 10.1016/j.thromres.2018.06.011. Epub 2018 Jun 15.

PMID:
30029070
12.

Genomic insights into the causes of type 2 diabetes.

Langenberg C, Lotta LA.

Lancet. 2018 Jun 16;391(10138):2463-2474. doi: 10.1016/S0140-6736(18)31132-2. Review.

PMID:
29916387
13.

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.

Gusarova V, O'Dushlaine C, Teslovich TM, Benotti PN, Mirshahi T, Gottesman O, Van Hout CV, Murray MF, Mahajan A, Nielsen JB, Fritsche L, Wulff AB, Gudbjartsson DF, Sjögren M, Emdin CA, Scott RA, Lee WJ, Small A, Kwee LC, Dwivedi OP, Prasad RB, Bruse S, Lopez AE, Penn J, Marcketta A, Leader JB, Still CD, Kirchner HL, Mirshahi UL, Wardeh AH, Hartle CM, Habegger L, Fetterolf SN, Tusie-Luna T, Morris AP, Holm H, Steinthorsdottir V, Sulem P, Thorsteinsdottir U, Rotter JI, Chuang LM, Damrauer S, Birtwell D, Brummett CM, Khera AV, Natarajan P, Orho-Melander M, Flannick J, Lotta LA, Willer CJ, Holmen OL, Ritchie MD, Ledbetter DH, Murphy AJ, Borecki IB, Reid JG, Overton JD, Hansson O, Groop L, Shah SH, Kraus WE, Rader DJ, Chen YI, Hveem K, Wareham NJ, Kathiresan S, Melander O, Stefansson K, Nordestgaard BG, Tybjærg-Hansen A, Abecasis GR, Altshuler D, Florez JC, Boehnke M, McCarthy MI, Yancopoulos GD, Carey DJ, Shuldiner AR, Baras A, Dewey FE, Gromada J.

Nat Commun. 2018 Jun 13;9(1):2252. doi: 10.1038/s41467-018-04611-z.

14.

Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.

Yarmolinsky J, Bonilla C, Haycock PC, Langdon RJQ, Lotta LA, Langenberg C, Relton CL, Lewis SJ, Evans DM; PRACTICAL Consortium, Davey Smith G, Martin RM.

J Natl Cancer Inst. 2018 Sep 1;110(9):1035-1038. doi: 10.1093/jnci/djy081.

15.

Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches.

Wittemans LBL, Lotta LA, Langenberg C.

Curr Diab Rep. 2018 May 19;18(7):40. doi: 10.1007/s11892-018-1009-1. Review.

16.

Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness.

Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, Matteini AM, Garton FC, Grarup N, Oskolkov N, Thalamuthu A, Mangino M, Liu J, Demirkan A, Lek M, Xu L, Wang G, Oldmeadow C, Gaulton KJ, Lotta LA, Miyamoto-Mikami E, Rivas MA, White T, Loh PR, Aadahl M, Amin N, Attia JR, Austin K, Benyamin B, Brage S, Cheng YC, Cięszczyk P, Derave W, Eriksson KF, Eynon N, Linneberg A, Lucia A, Massidda M, Mitchell BD, Miyachi M, Murakami H, Padmanabhan S, Pandey A, Papadimitriou I, Rajpal DK, Sale C, Schnurr TM, Sessa F, Shrine N, Tobin MD, Varley I, Wain LV, Wray NR, Lindgren CM, MacArthur DG, Waterworth DM, McCarthy MI, Pedersen O, Khaw KT, Kiel DP; GEFOS Any-Type of Fracture Consortium, Pitsiladis Y, Fuku N, Franks PW, North KN, van Duijn CM, Mather KA, Hansen T, Hansson O, Spector T, Murabito JM, Richards JB, Rivadeneira F, Langenberg C, Perry JRB, Wareham NJ, Scott RA.

Nat Commun. 2017 Jul 12;8:16015. doi: 10.1038/ncomms16015.

17.

Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes.

Mardinoglu A, Gogg S, Lotta LA, Stančáková A, Nerstedt A, Boren J, Blüher M, Ferrannini E, Langenberg C, Wareham NJ, Laakso M, Smith U.

EBioMedicine. 2018 Jan;27:151-155. doi: 10.1016/j.ebiom.2017.12.008. Epub 2017 Dec 7.

18.

PCSK9 inhibition and type 2 diabetes.

Lotta LA, Griffin SJ.

Lancet Diabetes Endocrinol. 2017 Dec;5(12):926-927. doi: 10.1016/S2213-8587(17)30321-2. Epub 2017 Sep 15. No abstract available.

PMID:
28927707
19.

Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease.

Mardinoglu A, Stančáková A, Lotta LA, Kuusisto J, Boren J, Blüher M, Wareham NJ, Ferrannini E, Groop PH, Laakso M, Langenberg C, Smith U.

Cell Metab. 2017 Aug 1;26(2):281-283. doi: 10.1016/j.cmet.2017.07.006.

20.

Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.

Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, Gaulton KJ, Eicher JD, Sharp SJ, Luan J, Rolfe EL, Stewart ID, Wheeler E, Willems SM, Adams C, Yaghootkar H; EPIC-InterAct Consortium; Cambridge FPLD1 Consortium, Forouhi NG, Khaw KT, Johnson AD, Semple RK, Frayling T, Perry JR, Dermitzakis E, McCarthy MI, Barroso I, Wareham NJ, Savage DB, Langenberg C, O'Rahilly S, Scott RA.

Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317c. No abstract available.

PMID:
28138151
21.

Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.

Lotta LA, Scott RA, Sharp SJ, Burgess S, Luan J, Tillin T, Schmidt AF, Imamura F, Stewart ID, Perry JR, Marney L, Koulman A, Karoly ED, Forouhi NG, Sjögren RJ, Näslund E, Zierath JR, Krook A, Savage DB, Griffin JL, Chaturvedi N, Hingorani AD, Khaw KT, Barroso I, McCarthy MI, O'Rahilly S, Wareham NJ, Langenberg C.

PLoS Med. 2016 Nov 29;13(11):e1002179. doi: 10.1371/journal.pmed.1002179. eCollection 2016 Nov.

22.

Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.

Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, Gaulton KJ, Eicher JD, Sharp SJ, Luan J, De Lucia Rolfe E, Stewart ID, Wheeler E, Willems SM, Adams C, Yaghootkar H; EPIC-InterAct Consortium; Cambridge FPLD1 Consortium, Forouhi NG, Khaw KT, Johnson AD, Semple RK, Frayling T, Perry JR, Dermitzakis E, McCarthy MI, Barroso I, Wareham NJ, Savage DB, Langenberg C, O'Rahilly S, Scott RA.

Nat Genet. 2017 Jan;49(1):17-26. doi: 10.1038/ng.3714. Epub 2016 Nov 14.

23.

Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.

Pagliari MT, Lotta LA, de Haan HG, Valsecchi C, Casoli G, Pontiggia S, Martinelli I, Passamonti SM, Rosendaal FR, Peyvandi F.

PLoS One. 2016 Nov 1;11(11):e0165665. doi: 10.1371/journal.pone.0165665. eCollection 2016.

24.

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.

Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, Boeing H, Deloukas P, Forouhi NG, Franks PW, Grioni S, Kaaks R, Key TJ, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Riboli E, Rolandsson O, Sacerdote C, Salamanca EC, Slimani N, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, McCarthy MI, Barroso I, O'Rahilly S, Savage DB, Sattar N, Langenberg C, Scott RA, Wareham NJ.

JAMA. 2016 Oct 4;316(13):1383-1391. doi: 10.1001/jama.2016.14568.

25.

Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease.

Yaghootkar H, Lotta LA, Tyrrell J, Smit RA, Jones SE, Donnelly L, Beaumont R, Campbell A, Tuke MA, Hayward C, Ruth KS, Padmanabhan S, Jukema JW, Palmer CC, Hattersley A, Freathy RM, Langenberg C, Wareham NJ, Wood AR, Murray A, Weedon MN, Sattar N, Pearson E, Scott RA, Frayling TM.

Diabetes. 2016 Aug;65(8):2448-60. doi: 10.2337/db15-1671. Epub 2016 Apr 26.

26.

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients.

Gorski MM, Blighe K, Lotta LA, Pappalardo E, Garagiola I, Mancini I, Mancuso ME, Fasulo MR, Santagostino E, Peyvandi F.

Blood. 2016 Jun 9;127(23):2924-33. doi: 10.1182/blood-2015-12-685735. Epub 2016 Apr 8.

27.

Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis.

Gorski MM, Lotta LA, Pappalardo E, de Haan HG, Passamonti SM, van Hylckama Vlieg A, Martinelli I, Peyvandi F.

PLoS One. 2016 Mar 16;11(3):e0151347. doi: 10.1371/journal.pone.0151347. eCollection 2016.

28.

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.

Peyvandi F, Rossio R, Ferrari B, Lotta LA, Pontiggia S, Ghiringhelli Borsa N, Pizzuti M, Donadelli R, Piras R, Cugno M, Noris M.

J Thromb Haemost. 2016 Feb;14(2):340-5. doi: 10.1111/jth.13210. Epub 2016 Feb 1.

29.

Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis.

Lotta LA, Abbasi A, Sharp SJ, Sahlqvist AS, Waterworth D, Brosnan JM, Scott RA, Langenberg C, Wareham NJ.

Diabetes Care. 2015 Nov;38(11):2177-87. doi: 10.2337/dc15-1218. Review.

30.

Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis.

Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A; Australian National Endometrial Cancer Study Group (ANECS), Perry JR, Attia J, Dunning AM, Easton DF, Holliday E, Lotta LA, O'Mara T, McEvoy M, Pharoah PD, Scott RJ, Spurdle AB, Langenberg C, Wareham NJ, Scott RA.

J Natl Cancer Inst. 2015 Jul 1;107(9). pii: djv178. doi: 10.1093/jnci/djv178. Print 2015 Sep.

31.

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.

Østergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JR, Boehme KL, Walter S, Kauwe JS, Gibbons LE; Alzheimer’s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium, Larson EB, Powell JF, Langenberg C, Crane PK, Wareham NJ, Scott RA.

PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.

32.

Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR.

J Thromb Haemost. 2015 Aug;13(8):1396-404. doi: 10.1111/jth.13032. Epub 2015 Jul 14. Review.

33.

Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.

Ferrari B, Maino A, Lotta LA, Artoni A, Pontiggia S, Trisolini SM, Malato A, Rosendaal FR, Peyvandi F.

Orphanet J Rare Dis. 2014 Nov 28;9:193. doi: 10.1186/s13023-014-0193-6.

34.

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.

Rossio R, Lotta LA, Pontiggia S, Borsa NG, Garagiola I, Ardissino G, Mikovic D, Cugno M, Peyvandi F.

Haematologica. 2015 Mar;100(3):e87-9. doi: 10.3324/haematol.2014.111062. Epub 2014 Nov 7. No abstract available.

35.

Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.

Scott RA, Fall T, Pasko D, Barker A, Sharp SJ, Arriola L, Balkau B, Barricarte A, Barroso I, Boeing H, Clavel-Chapelon F, Crowe FL, Dekker JM, Fagherazzi G, Ferrannini E, Forouhi NG, Franks PW, Gavrila D, Giedraitis V, Grioni S, Groop LC, Kaaks R, Key TJ, Kühn T, Lotta LA, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sala N, Sánchez MJ, Schulze MB, Siddiq A, Slimani N, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, Yaghootkar H; RISC study group; EPIC-InterAct consortium, McCarthy MI, Semple RK, Riboli E, Walker M, Ingelsson E, Frayling TM, Savage DB, Langenberg C, Wareham NJ.

Diabetes. 2014 Dec;63(12):4378-4387. doi: 10.2337/db14-0319. Epub 2014 Jun 19.

36.

FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.

Mancini I, Valsecchi C, Lotta LA, Deforche L, Pontiggia S, Bajetta M, Palla R, Vanhoorelbeke K, Peyvandi F.

Thromb Haemost. 2014 Aug;112(2):297-303. doi: 10.1160/TH13-08-0688. Epub 2014 Apr 17.

PMID:
24740645
37.

Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.

Lotta LA, Valsecchi C, Pontiggia S, Mancini I, Cannavò A, Artoni A, Mikovic D, Meloni G, Peyvandi F.

J Thromb Haemost. 2014;12(3):329-36. doi: 10.1111/jth.12494.

38.

Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery.

Musallam KM, Rosendaal FR, Zaatari G, Soweid A, Hoballah JJ, Sfeir PM, Zeineldine S, Tamim HM, Richards T, Spahn DR, Lotta LA, Peyvandi F, Jamali FR.

JAMA Surg. 2013 Aug;148(8):755-62. doi: 10.1001/jamasurg.2013.2360.

PMID:
23784299
39.

Raised haematocrit concentration and the risk of death and vascular complications after major surgery.

Musallam KM, Porter JB, Sfeir PM, Tamim HM, Richards T, Lotta LA, Peyvandi F, Jamali FR.

Br J Surg. 2013 Jul;100(8):1030-6. doi: 10.1002/bjs.9176.

PMID:
23754644
40.

Preoperative hematocrit concentration and the risk of stroke in patients undergoing isolated coronary-artery bypass grafting.

Musallam KM, Jamali FR, Rosendaal FR, Richards T, Spahn DR, Khavandi K, Barakat I, Demoss B, Lotta LA, Peyvandi F, Sfeir PM.

Anemia. 2013;2013:206829. doi: 10.1155/2013/206829. Epub 2013 Apr 30.

41.

Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis.

Lotta LA, Tuana G, Yu J, Martinelli I, Wang M, Yu F, Passamonti SM, Pappalardo E, Valsecchi C, Scherer SE, Hale W 4th, Muzny DM, Randi G, Rosendaal FR, Gibbs RA, Peyvandi F.

J Thromb Haemost. 2013 Jul;11(7):1228-39. doi: 10.1111/jth.12291.

42.

Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects.

Lotta LA, Maino A, Tuana G, Rossio R, Lecchi A, Artoni A, Peyvandi F.

PLoS One. 2013;8(4):e60396. doi: 10.1371/journal.pone.0060396. Epub 2013 Apr 2.

43.

The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura.

Lotta LA, Wu HM, Musallam KM, Peyvandi F.

Blood Rev. 2013 Mar;27(2):71-6. doi: 10.1016/j.blre.2013.01.001. Epub 2013 Feb 14. Review.

PMID:
23415418
44.

Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.

Lotta LA, Degasperi E, Aghemo A, Ferrari B, Peyvandi F, Colombo M.

Transfus Med. 2013 Feb;23(1):66-8. doi: 10.1111/j.1365-3148.2012.01197.x. Epub 2012 Oct 29. No abstract available.

PMID:
23106108
45.

Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort.

Rubattu S, Giusti B, Lotta LA, Peyvandi F, Cotugno M, Stanzione R, Marchitti S, Palombella AM, Di Castro S, Rasura M, Mannucci PM, Volpe M.

Eur J Intern Med. 2013 Jan;24(1):80-2. doi: 10.1016/j.ejim.2012.09.002. Epub 2012 Sep 18.

PMID:
22995222
46.

Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura.

Lotta LA, Wu HM, Cairo A, Bentivoglio G, Peyvandi F.

Blood Cells Mol Dis. 2013 Jan;50(1):59-60. doi: 10.1016/j.bcmd.2012.08.001. Epub 2012 Sep 11. No abstract available.

PMID:
22981442
47.

Prothrombin mutation conveying antithrombin resistance.

Lotta LA, Martinelli I, Peyvandi F.

N Engl J Med. 2012 Sep 13;367(11):1069; author reply 1069-70. doi: 10.1056/NEJMc1208510. No abstract available.

PMID:
22970962
48.

ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura.

Bettoni G, Palla R, Valsecchi C, Consonni D, Lotta LA, Trisolini SM, Mancini I, Musallam KM, Rosendaal FR, Peyvandi F.

J Thromb Haemost. 2012 Aug;10(8):1556-65. doi: 10.1111/j.1538-7836.2012.04808.x.

49.

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.

Lotta LA, Wu HM, Mackie IJ, Noris M, Veyradier A, Scully MA, Remuzzi G, Coppo P, Liesner R, Donadelli R, Loirat C, Gibbs RA, Horne A, Yang S, Garagiola I, Musallam KM, Peyvandi F.

Blood. 2012 Jul 12;120(2):440-8. doi: 10.1182/blood-2012-01-403113. Epub 2012 Apr 23.

50.

Measurement of anti-ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays.

Mancini I, Valsecchi C, Palla R, Lotta LA, Peyvandi F.

J Thromb Haemost. 2012 Jul;10(7):1439-42. doi: 10.1111/j.1538-7836.2012.04744.x. No abstract available.

Supplemental Content

Loading ...
Support Center